Investment Stage

Focus Areas

About Investor

Pranav Seshadri serves as a TechBio Investor at T.Rx Capital, where he focuses on investments at the intersection of technology and biology, particularly in early-stage biotech startups from seed through Series B, with typical investment ranges between $500K - $5.0M. Based in Connecticut, Pranav joined T.Rx Capital in December 2023 and brings experience from his previous roles as a Biotech Network Partner and Board Member at Sena Institute of Technology. His work at T.Rx Capital involves supporting the firm's $77.5 million Fund I, which targets early-stage investments across healthcare with a focus on company creation through Series B. Pranav combines his analytical skills with a passion for biotechnology innovation in his investment approach.